Regeneron settles lawsuit with partner Sanofi over information access and audit rights for Dupixent®.

{
  "signal_id": "bf3a1c26-ab2d-47eb-ab3a-be7decbee4bd",
  "signal_type": "sec-8k",
  "signal_subtype": "litigationMaterial",
  "detected_at": "2026-10-13T07:04:59.03+00:00",
  "company": {
    "name": "Regeneron",
    "domain": "regeneron.com"
  },
  "data": {
    "detail": "The settlement resolves a dispute concerning Sanofi's obligation to provide full access to commercialization data, highlighting a critical need for robust information sharing and auditing platforms, especially as their collaboration expands significantly.",
    "metrics": {
      "timeframe": "immediate"
    },
    "summary": "Regeneron settles lawsuit with partner Sanofi over information access and audit rights for Dupixent®.",
    "excerpts": "In connection with the execution of the Sixth Amendment, Regeneron and Sanofi entered into a settlement agreement pursuant to which Regeneron agreed to dismiss its lawsuit concerning Sanofi’s obligation to provide Regeneron with full access to material information relating to the commercialization of Dupixent® (dupilumab) and other products commercialized pursuant to the Antibody LCA, and Regeneron’s audit rights under the Antibody LCA.",
    "relevance": 0.7,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926113895/tm2627077d1_8k.htm",
    "filing_date": "2026-10-06",
    "filing_year": 2026,
    "sales_relevance": "Legal tech opportunity",
    "signal_category": "risk"
  }
}

curl https://signals.autobound.ai/v1/signals/bf3a1c26-ab2d-47eb-ab3a-be7decbee4bd \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"regeneron.com","limit":20}'